Maryland, Pennsylvania, Georgia and New York saw at least a 5 percent yearly rate of decline in new cases between 2008 and 2014.

People with HIV taking Viread, especially if combined with Norvir, should receive regular kidney monitoring.

One underground site has operated for almost three years and has reduced both injection in public spaces and unsafe syringe disposal.

Following a recent finding of a major drop in HIV diagnoses at the 56 Dean St. clinic, the decline in gonorrhea diagnoses is encouraging.

Having taken Kaletra also raised the risk of erectile dysfunction in a recent study of this group.

In a national survey, men who have sex with men also cited anticipated difficulty accessing PrEP as a reason for not taking it.

A Dutch study that offered men Truvada as prevention under either dosing protocol helps shed light on that question.

A package of enhanced antimicrobial prophylactic medications cut the death risk in those starting HIV treatment with fewer than 100 CD4s.

A recent study of people with HIV in Chicago found worrisome signs that they are not reaping the potential benefits of the medications.